Uncategorized

Harnessing cancer’s methylation footprint for more precise diagnosis and prognosis

Anne LI                                      6/30/2017                                    anne2001.li@gmail.com

 

In a new study, published online in the July 26 issue of PNAS, researchers at University of California San Diego School of Medicine, with colleagues in Xijing Hospital and Sun Yat-sen Cancer Center in China, report that DNA methylation can provide effective markers for at least four major cancers, not only correctly differentiating malignant tissues from normal, but also providing information on prognosis and survival. "Choosing the proper cancer treatment with the best chance of recovery and survival depends greatly upon accurately diagnosing the specific type or subtype of cancer," said Kang Zhang, MD, PhD, founding director of the Institute for Genomic Medicine and co-director of biomaterials and tissue engineering at the Institute of Engineering in Medicine, both at UC San Diego School of Medicine. "If you can do that using a minimally invasive biopsy, it has significant implications for cancer science and medicine. Using DNA methylation markers may be a new and more effective a way forward."

 

See original article at: https://www.sciencedaily.com/releases/2017/06/170627142827.htm

 

Comment(1)

  1. Kelthemia says

    Licensed Pharmacist India Levitra Headache What Does Tadalis Sx Soft Do Cialis On Sale Online Worldwide Stendra 100mg Legally

Post a comment